Medicare Enrolled
Dr. Paul Norwood, M.D., F.A.C.P.
Endocrinology · Fresno, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Norwood from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Norwood?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Norwood
Dr. Paul Norwood is an endocrinology specialist in Fresno, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Norwood performed 44,362 Medicare services across 1,697 unique beneficiaries.
Between the years covered by Open Payments, Dr. Norwood received a total of $32,178 from 61 pharmaceutical and/or device companies across 753 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Norwood is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 1% volume in CA
$32,178 industry payments
Medicare Practice Summary
Medicare Utilization ↗44,362
Medicare services
Top 1% in CA for endocrinology
1,697
Unique beneficiaries
$5
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~2,335 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Testosterone injection An injection of testosterone cypionate, a form of testosterone hormone. The dose is measured in milligrams. |
40,000 | $0 | $0 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,967 | $83 | $175 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
805 | $9 | $30 |
| Blood glucose level test A test that measures the amount of sugar in your blood. |
769 | $4 | $15 |
| Continuous glucose monitoring with interpretation This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results. |
252 | $26 | $60 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
165 | $11 | $40 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
91 | $30 | $34 |
| New patient office visit, complex (60-74 min) | 89 | $153 | $275 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
67 | $72 | $100 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
30 | $52 | $125 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
25 | $9 | $15 |
| Quadrivalent influenza vaccine, cell culture-derived A flu shot that protects against four strains of the influenza virus. It is produced using cell culture technology rather than traditional egg-based methods. |
24 | $32 | $35 |
| Ultrasound of head and neck soft tissue This procedure uses sound waves to create images of the soft tissues in the head and neck area. It allows for the visualization of structures beneath the skin without using radiation. |
21 | $94 | $175 |
| Continuous glucose monitoring, tissue fluid This procedure involves continuous monitoring of blood sugar levels in tissue fluid using a sensor placed under the skin. |
17 | $46 | $110 |
| Ultrasound-guided fine needle aspiration biopsy, first lesion A biopsy procedure where a thin needle is used to collect tissue samples from a growth, guided by ultrasound imaging. This code applies to the first lesion or mass sampled during the session. |
14 | $107 | $200 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
14 | $51 | $150 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
12 | $2 | $15 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$32,178
Total received (2018-2024)
Avg $4,597/year across 7 years
Top 10% in CA for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
61
Companies
753
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$18,936 (58.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$9,072 (28.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$4,170 (13.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,498
2023
$2,135
2022
$2,425
2021
$2,236
2020
$2,268
2019
$7,871
2018
$13,745
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$253
Lilly USA, LLC
$247
Abbott Laboratories
$180
Lexicon Pharmaceuticals, Inc.
$125
Saluda Medical Americas, Inc.
$101
Tandem Diabetes Care, Inc.
$95
Alexion Pharmaceuticals, Inc.
$95
Mannkind Corporation
$44
Ascensia Diabetes Care Us Inc.
$42
Amgen Inc.
$31
Kyowa Kirin, Inc.
$30
GENZYME CORPORATION
$28
Radius Health, Inc.
$27
Ultragenyx Pharmaceutical Inc.
$24
CeQur Corporation
$24
Dexcom, Inc.
$24
PFIZER INC.
$23
Boehringer Ingelheim Pharmaceuticals, Inc.
$22
Phathom Pharmaceuticals, Inc.
$20
SANOFI-AVENTIS U.S. LLC
$18
SANOFI PASTEUR INC.
$16
Amphastar Pharmaceuticals, Inc.
$15
Xeris Pharmaceuticals, Inc.
$14
Top 3 companies account for 45.4% of 2024 payments
All-time payments by company (2018-2024) ›
SANOFI-AVENTIS U.S. LLC
$11,044
Horizon Therapeutics plc
$4,532
Eli Lilly and Company
$4,492
Novo Nordisk Inc
$1,677
Lilly USA, LLC
$1,609
AstraZeneca Pharmaceuticals LP
$1,493
Abbott Laboratories
$902
Boehringer Ingelheim Pharmaceuticals, Inc.
$451
Insulet Corporation
$363
Corcept Therapeutics
$339
Shire North American Group Inc
$331
Nevro Corp.
$324
Medtronic, Inc.
$314
Dexcom, Inc.
$306
Takeda Pharmaceuticals U.S.A., Inc.
$267
Merck Sharp & Dohme Corporation
$250
Mannkind Corporation
$221
Tandem Diabetes Care, Inc.
$211
Medtronic MiniMed, Inc.
$198
Amgen Inc.
$194
Xeris Pharmaceuticals, Inc.
$190
Amarin Pharma Inc.
$153
Becton, Dickinson and Company
$141
Ultragenyx Pharmaceutical Inc.
$141
Lexicon Pharmaceuticals, Inc.
$125
Bayer HealthCare Pharmaceuticals Inc.
$124
Alexion Pharmaceuticals, Inc.
$111
Biohaven Pharmaceuticals, Inc.
$107
PFIZER INC.
$104
MannKind Corporation
$104
Radius Health, Inc.
$102
Saluda Medical Americas, Inc.
$101
Novartis Pharmaceuticals Corporation
$99
Ascensia Diabetes Care Us Inc.
$90
Edwards Lifesciences Corporation
$81
Eisai Inc.
$71
Kyowa Kirin, Inc.
$67
Janssen Pharmaceuticals, Inc
$66
Supernus Pharmaceuticals, Inc.
$57
SANOFI PASTEUR INC.
$50
Bayer Healthcare Pharmaceuticals Inc.
$46
Biohaven Pharmaceutical Holding Company Ltd.
$46
GENZYME CORPORATION
$44
GRT US Holding, Inc.
$44
LifeScan, Inc.
$42
CeQur Corporation
$40
DERMIRA, INC.
$35
Strongbridge US INC.
$35
RECORDATI_RARE_DISEASES_INC.
$27
VistaPharm, Inc.
$23
Ascendis Pharma Inc
$23
Companion Medical, Inc.
$22
Phathom Pharmaceuticals, Inc.
$20
IDORSIA PHARMACEUTICALS US INC
$18
Bigfoot Biomedical Inc
$17
DEXCOM, INC.
$17
NESTLE HEALTHCARE NUTRITION INC.
$16
Esperion Therapeutics, Inc.
$16
Amphastar Pharmaceuticals, Inc.
$15
Sun Pharmaceutical Industries Inc.
$15
AbbVie, Inc.
$13
Top 3 companies account for 62.4% of all-time payments
Associated products mentioned in payments ›
ACCURIAN · AFREZZA · AIMOVIG · Aimovig · BAQSIMI · BD Nano · BD Nano 2nd Gen Pen Needle · BREZTRI · CHANTIX · COLOGUARD DNA CAPTURE REAGENTS · Carpentier-Edwards PERIMOUNT Magna Ease Pericardial Aortic Bioprosthesis · CeQur Simplicity · Creon · Crysvita · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · DIABETES - DISEASE · Dayvigo · Dexcom G6 Transmitter · EMGALITY · EVENITY · EVERSENSE E3 SENSOR KIT - RETAIL · Evoke · FARXIGA · FLUZONE HIGH-DOSE · FORTEO · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · GLUCAGON · GVOKE HYPOPEN · GVOKE PFS · HUMULIN · HUMULIN R 500 · HUMULIN U · INPEN SMART INSULIN DELIVERY SYSTEM · INTELLIS ADAPTIVESTIM · INVOKANA · InPen · Inpefa · JANUVIA · JARDIANCE · KEVEYIS · KRYSTEXXA · Kerendia · Korlym · LYRICA · MINIMED 770G · MINIMED 780G · MOUNJARO · Minimed 670G System · NATPARA · NATPARA (PARATHYROID HORMONE) · NEXLETOL · NURTEC ODT · OT Verio Reflect "One Touch Meter and Strips" · Omnia · Omnipod · OneTouch · Ozempic · PREVNAR 20 · PROCLAIM · Prolia · QBREXZA · QELBREE · QUVIVIQ · Qutenza · RECORLEV · REYVOW · RIOMET ER · RYBELSUS · Rybelsus · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SOMAVERT · SOTAGLIFLOZIN · STRENSIQ · SYNJARDY · Senza · Strensiq · TEPEZZA · TOUJEO · TRADJENTA · TRINTELLIX · TRULICITY · TZIELD · Thyquidity · Trintellix · Tymlos · UNITY DIABETES MANAGEMENT SYSTEM · VOQUEZNA · Vascepa · Victoza · Wegovy · XARELTO · XENPOZYME · ZENPEP · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (59%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 10% for endocrinology in CA.
Geographic Context
Endocrinologists within 10 mi
13
Per 100K population
1.3
County median income
$71,434
Nearest hospital
SAINT AGNES MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Norwood is a mixed practice specialist, with above-average Medicare volume (top 1% in CA), with low-engagement industry engagement in the top 10% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Norwood experienced with testosterone injection?
Based on Medicare claims data, Dr. Norwood performed 40,000 testosterone injection services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Norwood receive payments from pharmaceutical companies?
Yes. Dr. Norwood received a total of $32,178 from 61 companies across 753 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Norwood's costs compare to other endocrinologists in Fresno?
Dr. Norwood's average Medicare payment per service is $5. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Norwood) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologists in Fresno
Browse endocrinologists in Fresno ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologists in CA
Endocrinologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologists in CA
Which CA endocrinologists receive the most from drug and device companies.
By company
SANOFI-AVENTIS U.S. LLC Payments to Doctors
See all physicians who received payments from SANOFI-AVENTIS U.S. LLC.
By company
Horizon Therapeutics plc Payments to Doctors
See all physicians who received payments from Horizon Therapeutics plc.
By company
Eli Lilly and Company Payments to Doctors
See all physicians who received payments from Eli Lilly and Company.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology